Study summary · 2024 · Evidence review
Heart-failure telehealth: pooled benefits and mixed studies
Pooled one-year outcomes favored monitoring, but narrative findings were mixed and the review combines different designs and technologies.
Summary by Vironix Health · Source review: November 11, 2026
How we select and interpret evidence
Original publication
Vittorio Masotta; Angelo Dante; Valeria Caponnetto; Alessia Marcotullio; Fabio Ferraiuolo; Luca Bertocchi; Francesco Camero; Loreto Lancia; Cristina Petrucci
University of L’Aquila, Italy
Heart & Lung · Online: · Issue: March 2024
Journal version of record. · Full text consulted.
What was studied
- Design
- Evidence review
- Population
- Heart-failure populations across NYHA classes
- Sample
- 61 studies; 17 contributed to meta-analyses
- Intervention
- Mixed telemonitoring, telephone support and implanted-device monitoring
- Comparator
- Usual care
- Follow-up
- One-year pooled endpoints; variable follow-up in narrative synthesis
- Review search cutoff
- 2021-08
- Setting
- Multiple countries
Methods
Random-effects meta-analyses combined eligible randomized and observational studies. The search predates publication by more than two years.
Findings
One-year mortality OR was 0.54 (95% CI 0.39–0.76; I² 56.39%); rehospitalization OR was 0.56 (0.40–0.80; I² 77.79%). The broader narrative synthesis did not show consistent rehospitalization benefit.
Limitations
High heterogeneity, observational confounding, language restrictions and an unregistered protocol limit certainty. Subgroup comparisons do not isolate causal program components. Trials overlap with other heart-failure reviews.
What this means for care delivery
These odds ratios are not relative risk reductions. Interpret the favorable pooled subset alongside the mixed narrative evidence, rather than applying its average effect to every RPM service.